Bio Key International Stock Target Price
| BKYI Stock | USD 0.87 0.06 6.45% |
BIO Key International fundamentals help investors to digest information that contributes to BIO Key's financial success or failures. It also enables traders to predict the movement of BIO Stock. The fundamental analysis module provides a way to measure BIO Key's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIO Key stock.
BIO | Target Price |
BIO Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIO Key's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIO Key could also be used in its relative valuation, which is a method of valuing BIO Key by comparing valuation metrics of similar companies.BIO Key is currently under evaluation in target price category among its peers.
BIO Fundamentals
| Return On Equity | -4.58 | ||||
| Return On Asset | -0.56 | ||||
| Profit Margin | (0.92) % | ||||
| Operating Margin | (1.45) % | ||||
| Current Valuation | 4.01 M | ||||
| Shares Outstanding | 3.11 M | ||||
| Shares Owned By Insiders | 5.57 % | ||||
| Shares Owned By Institutions | 5.02 % | ||||
| Number Of Shares Shorted | 39.66 K | ||||
| Price To Earning | (2.55) X | ||||
| Price To Book | 25.18 X | ||||
| Price To Sales | 0.46 X | ||||
| Revenue | 7.75 M | ||||
| Gross Profit | 3.44 M | ||||
| EBITDA | (7.85 M) | ||||
| Net Income | (8.52 M) | ||||
| Cash And Equivalents | 4.89 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 365.35 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.50 X | ||||
| Book Value Per Share | (0.58) X | ||||
| Cash Flow From Operations | (3.79 M) | ||||
| Short Ratio | 0.16 X | ||||
| Earnings Per Share | (8.66) X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 43 | ||||
| Beta | 0.25 | ||||
| Market Capitalization | 3.25 M | ||||
| Total Asset | 4.52 M | ||||
| Retained Earnings | (125.01 M) | ||||
| Working Capital | (591.23 K) | ||||
| Current Asset | 9.88 M | ||||
| Current Liabilities | 1.72 M | ||||
| Net Asset | 4.52 M |
About BIO Key Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIO Key International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIO Key using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIO Key International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:Check out BIO Key Piotroski F Score and BIO Key Altman Z Score analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share 6.323 | Quarterly Revenue Growth (0.41) | Return On Assets (0.56) | Return On Equity (4.58) |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.